Pharming Q3 Earnings, Revenue Increase

MT newswire2026/10/27 08:13

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

04:13 AM EDT, 10/27/2026 (MT Newswires) -- Pharming Group (PHAR) reported Q3 earnings Tuesday of $0.03 per diluted share, up from $0.01 a year earlier. A single analyst polled by FactSet expected $0.04. Revenue for the quarter ended Sept. 30 was $117.6 million, up from $97.3 million a year earlier. Two analysts expected $117.6 million. For 2026, the company said it now expects revenue between $380 million and $390 million, compared with its previous guidance range of $375 million to $395 million. Analysts expect $381.9 million.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

According to reports, the trading firm JonesTrading is marketing up to $500 million worth of stock shares on behalf of some investors, at a 3% to 5% premium over the IPO issue price. This indicates that investors are already transferring their anticipated IPO allotted shares before the IPO is officially issued.

华尔街见闻•2026/11/10 23:03